104 related articles for article (PubMed ID: 26785889)
1. Blood Myeloid Dendritic Cells and slanDC in Antiretroviral Therapy- Suppressed HIV-Infected Patients.
Lichtner M; Rossi R; Vita S; Savinelli S; Iannetta M; Mascia C; Marocco R; Ajassa C; Mengoni F; Scorzolini L; Maria Mastroianni C; Vullo V
Curr HIV Res; 2016; 14(4):331-9. PubMed ID: 26785889
[TBL] [Abstract][Full Text] [Related]
2. Myeloid and lymphoid activation markers in AIDS and non-AIDS presenters.
Iannetta M; Savinelli S; Rossi R; Mascia C; Marocco R; Vita S; Zuccalà P; Zingaropoli MA; Mengoni F; Massetti AP; Falciano M; d'Ettorre G; Ciardi MR; Mastroianni CM; Vullo V; Lichtner M
Immunobiology; 2019 Mar; 224(2):231-241. PubMed ID: 30522891
[TBL] [Abstract][Full Text] [Related]
3. Brief Report: Soluble CD163 in CMV-Infected and CMV-Uninfected Subjects on Virologically Suppressive Antiretroviral Therapy in the ICONA Cohort.
Vita S; Lichtner M; Marchetti G; Mascia C; Merlini E; Cicconi P; Vullo V; Viale P; Costantini A; DʼArminio Monforte A;
J Acquir Immune Defic Syndr; 2017 Mar; 74(3):347-352. PubMed ID: 27828874
[TBL] [Abstract][Full Text] [Related]
4. Increased sCD163 and sCD14 Plasmatic Levels and Depletion of Peripheral Blood Pro-Inflammatory Monocytes, Myeloid and Plasmacytoid Dendritic Cells in Patients With Severe COVID-19 Pneumonia.
Zingaropoli MA; Nijhawan P; Carraro A; Pasculli P; Zuccalà P; Perri V; Marocco R; Kertusha B; Siccardi G; Del Borgo C; Curtolo A; Ajassa C; Iannetta M; Ciardi MR; Mastroianni CM; Lichtner M
Front Immunol; 2021; 12():627548. PubMed ID: 33777012
[TBL] [Abstract][Full Text] [Related]
5. Monocyte activation, HIV, and cognitive performance in East Africa.
Muñoz-Nevárez LA; Imp BM; Eller MA; Kiweewa F; Maswai J; Polyak C; Olwenyi OA; Allen IE; Rono E; Milanini B; Kibuuka H; Ake JA; Eller LA; Valcour VG
J Neurovirol; 2020 Feb; 26(1):52-59. PubMed ID: 31468471
[TBL] [Abstract][Full Text] [Related]
6. Markers of T Cell Exhaustion and Senescence and Their Relationship to Plasma TGF-β Levels in Treated HIV+ Immune Non-responders.
Shive CL; Freeman ML; Younes SA; Kowal CM; Canaday DH; Rodriguez B; Lederman MM; Anthony DD
Front Immunol; 2021; 12():638010. PubMed ID: 33868264
[No Abstract] [Full Text] [Related]
7. Reduced sTWEAK and increased sCD163 levels in HIV-infected patients: modulation by antiretroviral treatment, HIV replication and HCV co-infection.
Beltrán LM; Muñoz Hernández R; de Pablo Bernal RS; García Morillo JS; Egido J; Noval ML; Ferrando-Martinez S; Blanco-Colio LM; Genebat M; Villar JR; Moreno-Luna R; Moreno JA
PLoS One; 2014; 9(3):e90541. PubMed ID: 24594990
[TBL] [Abstract][Full Text] [Related]
8. Plasma Biomarkers of Human Immunodeficiency Virus-Related Systemic Inflammation and Immune Activation in Sub-Saharan Africa Before and During Suppressive Antiretroviral Therapy.
Kroeze S; Wit FW; Rossouw TM; Steel HC; Kityo CM; Siwale M; Akanmu S; Mandaliya K; de Jager M; Ondoa P; Reiss P; Rinke de Wit TF; Kootstra N; Hamers RL
J Infect Dis; 2019 Aug; 220(6):1029-1033. PubMed ID: 31086991
[TBL] [Abstract][Full Text] [Related]
9. Increased Systemic Inflammation and Gut Permeability Among Women With Treated HIV Infection in Rural Uganda.
Siedner MJ; Zanni M; Tracy RP; Kwon DS; Tsai AC; Kakuhire B; Hunt PW; Okello S
J Infect Dis; 2018 Aug; 218(6):922-926. PubMed ID: 29718342
[TBL] [Abstract][Full Text] [Related]
10. Plasma CXCL10, sCD163 and sCD14 Levels Have Distinct Associations with Antiretroviral Treatment and Cardiovascular Disease Risk Factors.
Castley A; Williams L; James I; Guelfi G; Berry C; Nolan D
PLoS One; 2016; 11(6):e0158169. PubMed ID: 27355513
[TBL] [Abstract][Full Text] [Related]
11. Short Communication: SCD14 and SCD163 Levels Are Correlated with VACS Index Scores: Initial Data from the Blunted Immune Recovery in CORE Patients with HIV (BIRCH) Cohort.
Williams B; Livak B; Bahk M; Keating SM; Adeyemi OM
AIDS Res Hum Retroviruses; 2016 Feb; 32(2):144-7. PubMed ID: 26366931
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-37 Expression Is Increased in Chronic HIV-1-Infected Individuals and Is Associated with Inflammation and the Size of the Total Viral Reservoir.
Højen JF; Rasmussen TA; Andersen KL; Winckelmann AA; Laursen RR; Gunst JD; Møller HJ; Fujita M; Østergaard L; Søgaard OS; Dinarello CA; Tolstrup M
Mol Med; 2015 Apr; 21(1):337-45. PubMed ID: 25879630
[TBL] [Abstract][Full Text] [Related]
13. Soluble CD163 and soluble CD14 plasma levels but not cellular HIV-DNA decrease during successful interferon-free anti-HCV therapy in HIV-1-HCV co-infected patients on effective combined anti-HIV treatment.
Parisi SG; Andreis S; Mengoli C; Menegotto N; Cavinato S; Scaggiante R; Andreoni M; Palù G; Basso M; Cattelan AM
Med Microbiol Immunol; 2018 Aug; 207(3-4):183-194. PubMed ID: 29523966
[TBL] [Abstract][Full Text] [Related]
14. Soluble CD14, CD163, and CD27 biomarkers distinguish ART-suppressed youth living with HIV from healthy controls.
Williams JC; Zhang X; Karki M; Chi YY; Wallet SM; Rudy BJ; Nichols SL; Goodenow MM; Sleasman JW
J Leukoc Biol; 2018 Apr; 103(4):671-680. PubMed ID: 29377283
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor 1 inversely relates to monocyte/macrophage activation markers in HIV.
Fourman LT; Czerwonka N; Shaikh SD; Stanley TL; Burdo TH; Williams KC; Fitch KV; Lo J; Grinspoon SK
AIDS; 2018 Apr; 32(7):927-932. PubMed ID: 29424780
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms in the CD14 gene are associated with monocyte activation and carotid intima-media thickness in HIV-infected patients on antiretroviral therapy.
Yong YK; Shankar EM; Westhorpe CLV; Maisa A; Spelman T; Kamarulzaman A; Crowe SM; Lewin SR
Medicine (Baltimore); 2016 Aug; 95(31):e4477. PubMed ID: 27495090
[TBL] [Abstract][Full Text] [Related]
17. Persistent high plasma levels of sCD163 and sCD14 in adult patients with measles virus infection.
Mascia C; Pozzetto I; Kertusha B; Marocco R; Del Borgo C; Tieghi T; Vita S; Savinelli S; Iannetta M; Vullo V; Lichtner M; Mastroianni CM
PLoS One; 2018; 13(5):e0198174. PubMed ID: 29795672
[TBL] [Abstract][Full Text] [Related]
18. HIV disease is associated with increased biomarkers of endothelial dysfunction despite viral suppression on long-term antiretroviral therapy in Botswana.
Mosepele M; Mohammed T; Mupfumi L; Moyo S; Bennett K; Lockman S; Hemphill LC; Triant VA
Cardiovasc J Afr; 2018 May/Jun 23; 29(3):155-161. PubMed ID: 29771268
[TBL] [Abstract][Full Text] [Related]
19. Plasma Soluble CD163 Level Independently Predicts All-Cause Mortality in HIV-1-Infected Individuals.
Knudsen TB; Ertner G; Petersen J; Møller HJ; Moestrup SK; Eugen-Olsen J; Kronborg G; Benfield T
J Infect Dis; 2016 Oct; 214(8):1198-204. PubMed ID: 27354366
[TBL] [Abstract][Full Text] [Related]
20. Antiretroviral therapy suppressed participants with low CD4+ T-cell counts segregate according to opposite immunological phenotypes.
Pérez-Santiago J; Ouchi D; Urrea V; Carrillo J; Cabrera C; Villà-Freixa J; Puig J; Paredes R; Negredo E; Clotet B; Massanella M; Blanco J
AIDS; 2016 Sep; 30(15):2275-87. PubMed ID: 27427875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]